Skip to main content

NL
FR
EN

Other information and services: www.belgium.be Logo of the Belgian Federal Authorities

Your medicine and health products

About the FAMHP
Jobs
Publications
Press
Contact
Complaints
Webportal

Search

Home
Human use
Veterinary use
Information for the public
Information for professionals

Home
Human use
Medicines
Current Page:Medicines

Medicines

COVID-19
- Research and development
- Vaccines
Scientific-technical advice
- Introduction
- Procedures
- Regulation
- Fees
- FAQ's
- Statistics
National Innovation Office
Research & Development
Marketing Authorisation procedures
Pharmacovigilance
Production
Distribution & Delivery
Autorisations - certificates
Declarations - Registrations
Proper use of medicine

Last updated on 16/12/2020

Notification of adverse reactions or incidents

PIL and SPC
of a medicine

(PIL: patient information leaflet SPC: summary of product characteristics)

News

19/01/2022

PRAC January 2022 – Review of terlipressin medicines started, update of COVID-19 vaccins and new safety information for Mavenclad

18/01/2022

Manufacturers, importers and distributors of human and veterinary medicines must check their data in the Organisation Management Service database of the EMA

17/01/2022

Give your opinion on a genetically modified medicine for the treatment of Duchenne muscular dystrophy

11/01/2022

Give your opinion on a genetically modified medicine for the treatment of various types of advanced cancer

© 2016 - FAMHP

Zeposia (Celgene)
Privacy
Disclaimer

instructions how to enable JavaScript in your web browser